Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CALM US Equity

Cal-Maine Foods IncConsumer Staples · Agricultural Prod-Livestock & Animal Specialties · CIK 16160 · FY ends May 30
$82.80
+0.37 (+0.45%)
USD · as of 2026-08-21 · marketstack

CALM · 10-K · period ended 2024-06-01

← all CALM documents
filed 2024-07-23 · EDGAR original ↗

Our rendering of the filing — original pagination and typography are not reproduced, and tables are reduced to their short label cells (the figures live on FA). Nothing is summarized: every line below is the filing's own text.

blocks 2,8693,468 of 16,361231k characters rendered

ITEM 1A.

RISK FACTORS

Our

business

and

results

of

operations

are

subject

to

numerous

risks

and

uncertainties,

many

of

which

are

beyond

our

control. The following is a description of the known factors that may materially affect

our business, financial condition or results

of operations. They

should be considered

carefully,

in addition

to the information

set forth

elsewhere in

this Annual

Report on

Form

10-K,

including

under

Part

II.

Item 7.

Management’s

Discussion

and

Analysis

of

Financial

Condition

and

Results

of

Operations,

in

making

any

investment

decisions

with

respect

to

our

securities. Additional

risks

or

uncertainties

that

are

not

currently known

to us,

or that we

are aware

of but

currently deem

to be

immaterial or

that could

apply to

any company

could

also materially adversely affect our business, financial condition or results

of operations.

INDUSTRY RISK FACTORS

Market prices

of wholesale

shell eggs

are volatile,

and decreases

in these

prices can

adversely impact

our revenues

and

profits.

Our operating results are significantly

affected by wholesale shell egg

market prices, which fluctuate widely and

are outside our

control. As

a result,

our prior

performance

should not

be presumed

to be

an accurate

indication of

future performance.

Under

certain circumstances, small increases

in production, or small

decreases in demand, within

the industry might

have a large adverse

effect on shell egg prices. Low shell egg prices adversely affect

our revenues and profits.

Market prices for

wholesale shell eggs

have been volatile

and cyclical. Shell

egg prices have

risen in the

past during periods

of

high demand such as the initial outbreak of

the COVID-19 pandemic and periods when high protein

diets are popular. Shell egg

prices

have

also

risen

during

periods

of

constrained

supply,

such

as

the

latest

highly

pathogenic

avian

influenza

(“HPAI”)

outbreak

that was

first detected

in domestic

commercial flocks

in February

2022. During

times when

prices are

high, the

egg

industry

has

typically

geared

up

to

produce

more

eggs,

primarily

by

increasing

the

number

of

layers,

which

historically

has

ultimately resulted in an oversupply of eggs, leading to a period of lower prices.

As discussed

above in

Part I.Item 1.Business –Seasonality

, seasonal fluctuations

impact shell

egg prices. Therefore,

comparisons

of

our

sales

and

operating

results

between

different

quarters

within

a

single

fiscal

year

are

not

necessarily

meaningful

comparisons.

A decline in consumer demand for shell eggs can negatively impact our business.

We believe high

-protein diet trends, industry advertising campaigns,

the improved nutritional reputation of eggs and an increase

in at-home consumption

of eggs during

the COVID-19 pandemic,

have all contributed

at one time or

another to increased

shell

egg demand. However, it is possible that the demand for shell eggs will decline in the future. Adverse publicity relating to health

or safety

concerns and

changes in

the perception

of the

nutritional

value

of shell

eggs,

changes in

consumer

views regarding

consumption of

animal-based products,

as well

as movement

away from

high protein

diets, could

adversely affect

demand for

shell eggs, which could have a material adverse effect on our future

results of operations and financial condition.

Feed costs are volatile and increases in these costs can

adversely impact our results of operations.

Feed costs are the largest element of our shell

egg (farm) production cost, ranging from 55%

to 63% of total farm production cost

in the last five fiscal years.

Although feed ingredients, primarily corn and soybean

meal, are available from a

number of sources, we do

not have control over

the prices

of the

ingredients we

purchase, which

are affected

by weather,

various global

and U.S.

supply and

demand factors,

transportation

and

storage

costs,

speculators,

and

agricultural,

energy

and

trade

policies

in

the

U.S.

and

internationally.

For

example, while feed

costs declined during fiscal

2024, we saw higher

prices for corn and soybean

meal in fiscal 2022

and 2023

as a result of

weather-related shortfalls in

production and yields,

ongoing supply chain

disruptions and the

Russia-Ukraine War

and its impact on the export markets. Our costs for corn and soybean meal

are also affected by local basis prices.

Increases in feed

costs unaccompanied by increases

in the selling price

of eggs can have

a material adverse effect

on the results

of our operations

and cash flow.

Alternatively,

low feed costs

can encourage

egg industry overproduction,

possibly resulting in

lower egg prices and lower revenue.

14

Agricultural risks,

including outbreaks

of avian

diseases such as

HPAI,

have harmed

and in

the future

could harm

our

business.

Our shell egg

production activities are

subject to a variety

of agricultural risks.

Unusual or extreme

weather conditions, disease

and pests can materially and adversely affect the quality and quantity of shell eggs

we produce and distribute. Outbreaks of avian

influenza among poultry

occur periodically worldwide

and have occurred

sporadically in the

U.S. Since the

HPAI

outbreaks in

2015, there were no reported

significant outbreaks of HPAI in the commercial table egg

layer flocks in the

U.S. until the February

– December

2022 time

period and

then again

beginning in

November 2023.

During the

third and

fourth quarters

of our

fiscal

2024, we

experienced HPAI

outbreaks within

our facilities

located in

Kansas and

Texas,

resulting in

total depopulation

of 3.1

million laying hens

and 577,000 pullets.

Both locations have

been cleared by

the USDA to resume

operations and repopulation

is expected to

be completed

before calendar

year end. As

of July 5,

2024, the

U.S. Centers for

Disease Control

and Prevention

(“CDC”) reported

outbreaks in 138

dairy herds in

12 states and

five cases in

the U.S. in

persons who were

exposed to infected

cows or poultry.

The CDC has not

reported any case of

human-to-human transmission. The

CDC considers that the

overall risk

to the general U.S. public

posed by the virus remains

low; however,

as a precautionary measure,

the U.S. Department of

Health

and

Human

Services

has

awarded

funding

to

Moderna

to

develop

a

human

vaccine

against

avian

influenza.

For

additional

information, refer to

Part II. Item 7. Management’sDiscussion and Analysis of Financial Conditionand Results of Operations –

HPAI

.

We

maintain

controls

and

procedures

designed

to reduce

the risk

of

exposing

our

flocks and

employees

to harmful

diseases;

however,

despite these

efforts, outbreaks

of avian

diseases can

and do

still occur

and have

adversely impacted,

and may

in the

future adversely impact, the health of our flocks and could in the future adversely impact the health of our employees. Continued

or intensified spread of HPAI could have a material adverse impact on our financial results

by increasing government restrictions

on the sale and

distribution of our products

and requiring us to

euthanize the affected

layers. Negative publicity

from outbreaks

within our industry

can negatively impact

customer perception. If

a substantial portion

of our layers

or production facilities

are

affected by any of these factors in any given quarter or year,

our business, financial condition, and results of operations could

be

materially and adversely affected.

Shell

eggs

and

shell

egg

products

are

susceptible

to

microbial

contamination,

and

we

may

be

required

to,

or we

may

voluntarily, recall

contaminated products.

Shell eggs

and shell

egg products

are vulnerable

to contamination

by pathogens

such as

Salmonella. The

Company maintains

policies and procedures designed to comply with the complex rules and regulations governing egg production, such as The Final

Egg

Rule

issued

by

the

FDA

“Prevention

of

Salmonella

Enteritidis

in

Shell

Eggs

During

Production,

Storage,

and

Transportation,” and

the FDA’s

Food Safety Modernization Act. Shipment

of contaminated products, even

if inadvertent, could

result in a

violation of law and

lead to increased

risk of exposure

to product liability

claims, product recalls

and scrutiny by

federal

and

state

regulatory

agencies.

We

have

little,

if

any,

control

over

proper

handling

once

the

product

has

been

shipped

or

delivered. In

addition,

products

purchased

from

other

producers

could

contain

contaminants

that

might

be

inadvertently

redistributed by us. As such, we might decide or be required

to recall a product if we, our customers

or regulators believe it poses

a potential

health risk.

Any product

recall could

result in

a loss

of consumer

confidence in

our products,

adversely affect

our

reputation

with existing

and potential

customers and

have a

material adverse

effect

on our

business, results

of operations

and

financial condition. We

currently maintain insurance

with respect to certain of

these risks, including product

liability insurance,

business

interruption

insurance,

product

recall

insurance

and

general

liability

insurance,

but

in

many

cases

such

insurance

is

expensive, difficult

to obtain

and no

Source: SEC EDGAR (public domain) · 10-K for the period ended 2024-06-01, filed 2024-07-23 · accession 0001562762-24-000177

Filing HTML rendered to line-structured narrative text by the shipped reducer (datafeeds.edgar_fulltext.visible_text, keep_table_headers=True): scripts and inline-XBRL headers are dropped, and table content is reduced to its short label cells — numeric table data is not rendered and is therefore not counted. The same rendering is used for every year, so a year-over-year comparison is like for like.

The text is our rendering of the filing, not a facsimile: original pagination, typography and tables are not reproduced, and the numbers live in the financial statements (FA).

The outline locates item HEADINGS in this document. Only Items 1A and 7 have certified boundaries elsewhere in the terminal (the redline and the narrative-overlap number); every span here runs from one heading found to the next heading found.

How the outline was chosen. It is the longest chain of item headings that runs forward through both the document and the standard item order: 19 headings are on that chain and 2 further heading-shaped lines are not — the table-of-contents echo of every item, cross-references and exhibit-list mentions. Each entry's length is measured from its heading to the next heading on the chain.